Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 03 May 2018
      News
 
  03 May 2018 03052018 Early Career Research Prize in Vaccinology R&D – 2nd edition

Promote and foster a younger generation of scientists in the early stages of their career!

Read more →
 
 
 
      Blogs
 
  03 May 2018 03052018 Nailing down the Future

"If all you have is a hammer, everything looks like a nail". In the hardware shop of data and digital policy, the hammer...

Read more →
 
 
 
  03 May 2018 03052018 Poland carries the Torch

Celebrating some of the many world’s scientific giants who lit the torch that we carry in the Innovative Medicines Initiative...

Read more →
 
 
 
      Videos
 
 
 
#WeWontRest for a Brighter Tomorrow
With over 7000 new medicines in development, #WeWontRest until everyone affected by disease can look forward to a brighter tomorrow
 
 
Fighting Cancer, For a Brighter Tomorrow
With over 1800 medicines in development we won’t rest until everyone affected by cancer sees a brighter tomorrow.
 
 
 
 
      Events
 
 
22 MAY 2018
  Unlocking tomorrow's cures European Parliament, Brussels

An exhibition to explore the cutting-edge science behind new treatments and how it is transforming patients’ lives

Learn more →
 
 
 
27 JUN 2018
  23042018 IMI: Celebrating 10 years of medical innovations Brussels

An event to highlight the successes of IMI projects, showcasing tangible results that are translated into concrete benefits...

Learn more →
 
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe